Sale of 7,765 shares at $6.96 per share.
Reporting Person Wilterding Mark · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001193125-26-380713 · filed 2026-09-02 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "RxSight, Inc. (RXST)." Disclosed 2026-09-02. https://desqlong.com/cards/0001193125-26-380713-2 (retrieved 2026-09-26).